Home › Hypertrophic Cardiomyopathy › Illinois › Chicago
Hypertrophic Cardiomyopathy clinical trials in Chicago, IL
3 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RecruitingObservational study
- University of Chicago Dept of Medicine, Chicago
Study of the Progression of Chronic Cardiovascular Conditions
RecruitingObservational study
- Prolaio, Chicago
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
RecruitingPhase 2
- Imbria Investigational Site, Chicago
Hypertrophic Cardiomyopathy trials in other cities
- Boston, MA6 studies
- San Francisco, CA4 studies
- Charlottesville, VA4 studies
- Cleveland, OH4 studies
- New York City, NY3 studies
- Charlotte, NC3 studies
- Houston, TX3 studies
- San Diego, CA3 studies
- Plano, TX3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.